Association between changes in thioredoxin reductase and other peripheral blood biomarkers with response to PD-1 inhibitor-based combination immunotherapy in non-small cell lung cancer: a retrospective study

BACKGROUND: Immunotherapy deeply changed the treatment paradigm of advanced non-small cell lung cancer (NSCLC) in the past years. However, the objective response rate (ORR) after immunotherapy is about 20–30% of NSCLC patients. Therefore, identification of predictive biomarkers is crucial for select...

Descripción completa

Detalles Bibliográficos
Autores principales: Wen, Shaodi, Du, Xiaoyue, Chen, Yuzhong, Xia, Jingwei, Wang, Ruotong, Zhu, Miaolin, Peng, Weiwei, Spitaleri, Gianluca, Hofman, Paul, Bironzo, Paolo, Wang, Xin, Shen, Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9186172/
https://www.ncbi.nlm.nih.gov/pubmed/35693285
http://dx.doi.org/10.21037/tlcr-22-300

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9186172/
https://www.ncbi.nlm.nih.gov/pubmed/35693285
http://dx.doi.org/10.21037/tlcr-22-300

Ejemplares similares